New monthly shot could keep severe asthma patients out of the ER

NCT ID NCT06705764

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times

Summary

This study tests whether starting Tezepelumab, a monthly injection, in the emergency room helps adults with severe asthma recover faster and avoid future attacks. About 100 adults aged 18-55 who use high-dose inhalers will get either Tezepelumab or a placebo alongside standard care. The goal is to see if the drug reduces the need for repeat ER visits and steroid pills.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sturgeon Community Hospital

    St. Albert, Alberta, T8N6C4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Alberta

    Edmonton, Ca-ab, T6G 2G3, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.